Abstract
Common treatment methods for patients with cervical intraepithelial neoplasia (CIN) include physical therapy and surgical treatment, and loop electrosurgical excisional procedure (LEEP) is relatively widely used in surgical treatment of CIN. However, some CIN patients were found margin positive of residual lesions in uterine specimens by biopsy after LEEP treatment, and the rate of margin positive of CIN was 4.51%-23.40%. A large number of studies have confirmed that margin positive of CIN is associated with postoperative residual lesions in uterine specimens by biopsy and recurrence of CIN. Further treatment strategies of patients with margins positive of CIN after LEEP treatment, no consensus has been reached in domestic and foreign studies of this area. At present, it is considered that the follow-up treatment of patients with CIN who have residual lesions and margins positive of CIN after receiving LEEP treatment need comprehensive evaluation and appropriate measures, especially for patients with positive of CIN in internal and external margins. This article focuses on latest research progresses of high-risk factors and treatment strategies in patients with margins positive of CIN after LEEP treatment, in order to provide reference for standardized clinical diagnosis and treatment of CIN patients. Key words: Cervical intraepithelial neoplasia; Uterine cervical neoplasms; Cervical resection; Hysterectomy; Loop electrosurgical excisional procedure; Margin positive of residual lesions; Biopsy; Female
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.